Carbon quantum dots (CQDs) are an emerging class of quasi-zero-dimensional
photoluminescent nanomaterials with particle sizes less than 10 nm. Owing to their …

The chemotherapeutic agent doxorubicin (Dox) is commonly used to treat various types of
cancer, even though it can cause life-threatening cardiotoxicity. Clinically, there is no …

Although recent years have seen a shift towards the use of targeted cancer therapy,
chemotherapy remains the backbone of treatment of most advanced or metastatic cancers …

Liposomes represent one of the most successful nano-drug delivery systems among
enormous nano-carriers. Although great progress has been made in conventional …

Despite efforts in osteosarcoma (OS) research, the role of inductive moderate hyperthermia
(IMH) in delivering and enhancing the antitumor effect of liposomal doxorubicin formulations …

Aggressive T-cell lymphomas (TCL) account for 10–15% of non-Hodgkin lymphomas (NHL)
with weaker responses and shorter durations to chemotherapy than other types of NHL …

Anthracyclines are a major cornerstone of oncology therapy in a variety of cancer entities.
However, cardiotoxicity presents an important acute and long-term side effect, especially as …

Cardio-oncology, a burgeoning subspecialty, addresses the complex interplay between
cardiology and oncology, particularly in light of increased cardiovascular (CV) disease …

Tyrosine kinase inhibitors (TKIs) are characterized as multi‑targeted anticancer agents that
lack specificity, leading to cardiovascular adverse effects. To date, there are no reliable …

For the delivery of anticancer drugs, an injectable in situ hydrogel with thermal
responsiveness and prolonged drug release capabilities shows considerable potential …